We are live on ! Find out more
REGN icon

Regeneron Pharmaceuticals
REGN

1,079 hedge funds and large institutions have $56.6B invested in Regeneron Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 175 funds opening new positions, 428 increasing their positions, 321 reducing their positions, and 97 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 175 | Existing positions closed: 97

33% more repeat investments, than reductions

Existing positions increased: 428 | Existing positions reduced: 321

6% more funds holding

Funds holding: 1,017 → 1,079 (+62)

4% more capital invested

Capital invested by funds: $54.4B → $56.6B (+$2.25B)

0.66% less ownership

Funds ownership: 86.01% → 85.34% (-0.66%)

12% less funds holding in top 10

Funds holding in top 10: 17 → 15 (-2)

33% less call options, than puts

Call options by funds: $985M | Put options by funds: $1.48B

Holders
1,079
Holders Change
+62
Holders Change %
+6.1%
% of All Funds
16.61%
Holding in Top 10
15
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-11.76%
% of All Funds
0.23%
New
175
Increased
428
Reduced
321
Closed
97
Calls
$985M
Puts
$1.48B
Net Calls
-$492M
Net Calls Change
-$207M

Top Buyers

1
JP Morgan Chase
JP Morgan Chase
New York
+$301M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$239M
3
Two Sigma Investments
Two Sigma Investments
New York
+$196M
4
Dodge & Cox
Dodge & Cox
California
+$172M
5
BlackRock
BlackRock
New York
+$150M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$618M
2
Capital International Investors
Capital International Investors
California
-$532M
3
AIM
ARK Investment Management
Florida
-$218M
4
Fidelity International
Fidelity International
Bermuda
-$162M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$143M
Name Holding Trade Value Shares
Change 		Change in
Stake
PT
501
Plimoth Trust
Massachusetts
$1.29M +$200K +326 +19%
PTC
502
Private Trust Company
Ohio
$1.27M -$81.2K -132 -6%
CA
503
Cornerstone Advisors
North Carolina
$1.26M – – –
SWA
504
Stratos Wealth Advisors
Ohio
$1.26M +$200K +325 +19%
NL
505
NWAM LLC
Washington
$1.26M +$702K +1,141 +135%
CAN
506
Cetera Advisor Networks
California
$1.25M -$174K -283 -13%
CIA
507
Capital Impact Advisors
Massachusetts
$1.23M -$2.84M -4,615 -70%
SVWAG
508
Sound View Wealth Advisors Group
Georgia
$1.23M -$1.23K -2 -0.1%
CHAM
509
Clear Harbor Asset Management
Connecticut
$1.23M +$8.61K +14 +0.7%
Polen Capital Management
510
Polen Capital Management
Florida
$1.22M -$133K -217 -10%
CA
511
Cetera Advisors
Colorado
$1.21M -$27.7K -45 -2%
AWM
512
Avior Wealth Management
Nebraska
$1.21M – – –
ECM
513
ExodusPoint Capital Management
New York
$1.21M +$483K +786 +69%
FIM
514
Freedom Investment Management
Connecticut
$1.2M +$30.1K +49 +3%
JCIA
515
Jackson Creek Investment Advisors
Colorado
$1.19M +$321K +522 +38%
CLOS
516
Compagnie Lombard Odier SCmA
Switzerland
$1.19M – – –
V
517
Veritable
Delaware
$1.18M +$89.8K +146 +9%
Nomura Holdings
518
Nomura Holdings
Japan
$1.17M -$349K -568 -23%
NFC
519
Northeast Financial Consultants
Connecticut
$1.16M – – –
WFI
520
West Family Investments
California
$1.15M -$125K -204 -10%
SWRP
521
Summit Wealth & Retirement Planning
California
$1.14M -$69.5K -113 -6%
LFM
522
Lumina Fund Management
New York
$1.14M – – –
Fayez Sarofim & Co
523
Fayez Sarofim & Co
Texas
$1.14M +$799K +1,300 +260%
AG
524
AIA Group
Hong Kong
$1.13M +$428K +696 +63%
EGM
525
Engineers Gate Manager
New York
$1.13M +$1.1M +1,783 New
19 20
21
22 23

REGN Hedge Fund Activity: Q4 2021 in Review

1,079 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Regeneron Pharmaceuticals (REGN) for Q4 2021, worth a combined $56.6B — up 4.1% from $54.4B a quarter earlier.

Buyers outnumbered sellers: 175 funds opened new REGN positions and 97 closed out — a net gain of 78 holders — while 428 added to existing stakes and 321 trimmed.

The largest buyer was JP Morgan Chase, adding an estimated $301M. The largest seller was Fidelity Investments, cutting an estimated $618M.

  • 1,079 institutional investors held Regeneron Pharmaceuticals (REGN) as of Q4 2021, up from 1,017 in Q3 2021.
  • Funds reported $56.6B of Regeneron Pharmaceuticals stock for Q4 2021, up 4.1% quarter-over-quarter.
  • 175 funds opened new Regeneron Pharmaceuticals positions in Q4 2021 and 97 closed out, a net change of +78 holders.
  • The largest Regeneron Pharmaceuticals buyer in Q4 2021 was JP Morgan Chase, an estimated $301M added.
  • The largest Regeneron Pharmaceuticals seller in Q4 2021 was Fidelity Investments, an estimated $618M sold.

Based on aggregated 13F filings for Q4 2021.